XML 57 R38.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Earnings (Loss) Per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
Schedule of Earnings Per Share | The calculations of basic and diluted earnings (loss) per share were as follows:
|  |  | Three Months Ended March 31,
|  |  |  |  | 2024 |  | 2023
Numerator: |  |  |  |  |  |  |
Net income (loss) |  |  |  |  | $ | 88,043 |  |  | $ | (34,422) |
Less: Redeemable preferred stock dividends |  |  |  |  | (10,079) |  |  | (9,968) |
Net income (loss) attributable to common stockholders – basic |  |  |  |  | $ | 77,964 |  |  | $ | (44,390) |
Plus: Dilutive effect of convertible notes, net(1) |  |  |  |  | (55,441) |  |  | — |
Net income (loss) attributable to common stockholders – diluted(1)(2) |  |  |  |  | $ | 22,523 |  |  | $ | (44,390) |
Denominator: |  |  |  |  |  |  |
Weighted average common stock outstanding – basic |  |  |  |  | 982,617,492 |  |  | 929,270,723 |
Effect of dilutive securities(2): |  |  |  |  |  |  |
Convertible notes |  |  |  |  | 47,845,642 |  |  | — |
Unvested RSUs |  |  |  |  | 9,752,440 |  |  | — |
Common stock options |  |  |  |  | 2,260,927 |  |  | — |
Weighted average common stock outstanding – diluted |  |  |  |  | 1,042,476,501 |  |  | 929,270,723 |
Earnings (loss) per share – basic |  |  |  |  | $ | 0.08 |  |  | $ | (0.05) |
Earnings (loss) per share – diluted |  |  |  |  | $ | 0.02 |  |  | $ | (0.05) |
________________________ (1)For the three months ended March 31, 2024, diluted earnings per share of $0.02 and diluted net income attributable to common stockholders of $22,523 exclude gain on extinguishment of debt, net of tax, associated with convertible note activity during the period, as well as interest expense incurred, net of tax, related to convertible notes due 2026. (2)During the three months ended March 31, 2024 and March 31, 2023, 81.0 million and 194.8 million shares, respectively, were excluded from the computation of diluted earnings per share, as the effect would have been anti-dilutive.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following table presents all potentially dilutive stock elements, and reflect the number of instruments outstanding at the end of the period.
| March 31,
| 2024 |  | 2023
Common stock options | 17,721,910 |  |  | 18,569,877 |
Common stock warrants | 12,170,990 |  |  | 12,170,990 |
Unvested RSUs(1) | 73,141,764 |  |  | 86,139,377 |
Unvested PSUs | 14,913,609 |  |  | 18,073,029 |
Convertible notes(2) | 22,841,631 |  |  | 53,538,000 |
Contingent common stock(3) | 45,859 |  |  | 6,305,595 |
________________________ (1)As of March 31, 2024, includes DSUs granted to non-employee directors. See Note 13. Share-Based Compensation for additional information. (2)Represents the shares of common stock issuable upon conversion of all convertible notes at the conversion rate in effect at the date indicated. As of March 31, 2024, the 2026 convertible notes are potentially convertible into 22,841,631 shares of common stock, and there are no shares of common stock expected to be issued relating to the 2029 convertible notes, as there was no amount in excess of the expected cash redemption price which would require share settlement. See Note 9. Debt for additional information. (3)Represents contingently returnable common stock in connection with the Technisys Merger, which consists of shares that continue to be held in escrow pending resolution of outstanding indemnification claims by SoFi. These shares were issued in 2022 and partially released in 2023. See Note 2. Business Combinations for additional information.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration